Cookie Einstellungen
Diese Webseite verwendet ausschließlich notwendige Cookies, die für die Funktion erforderlich sind. Marketing- und Statistik-Cookies kommen nicht zum Einsatz. Weitere Informationen finden Sie in unserer Datenschutzerklärung.
 Notwendig   Details einblenden
      OK      
Bitte logge Dich ein, um diese Funktion zu nutzen!
      OK      
x
Impact News +++ INOVIO Pharmaceuticals proposes securities offering (SeekingAlpha) +++ INOVIO Aktie -12,75%

RTW BIOTECH Aktie

>RTW BIOTECH Performance
1 Woche: -3,7%
1 Monat: -7,7%
3 Monate: -11,4%
6 Monate: +31,4%
1 Jahr: +43,5%
laufendes Jahr: -11,4%
>RTW BIOTECH Aktie
Name:  RTW BIOTECH OPPORTUNITIES
Land:  Großbritannien
Sektor:  Gesundheit
ISIN/ Wkn:  GG00BKTRRM22 / A2PUQN
Symbol/ Ticker:  0BM (Frankfurt)
Kürzel:  FRA:0BM, ETR:0BM, 0BM:GR
Index:  -
Webseite:  https://www.rtwfunds.com/..
Profil:  RTW Biotech Opportunities Ltd is a Guernsey-domiciled closed-end investment fund specializing in the life sciences sector. It focuses on identifying and investing in transformative assets with high growth potential across biopharmaceuticals and medic..
>Volltext..
Marktkapitalisierung:  544.7 Mio. EUR
Unternehmenswert:  670.43 Mio. EUR
Umsatz:  51.4 Mio. EUR
EBITDA:  -74.44 Mio. EUR
Nettogewinn:  -80.28 Mio. EUR
Gewinn je Aktie:  -0.25 EUR
Schulden:  109.76 Mio. EUR
Liquide Mittel:  2.31 Mio. EUR
Operativer Cashflow:  -12.23 Mio. EUR
Bargeldquote:  0.02
Umsatzwachstum:  656.14%
Gewinnwachstum:  -161.53%
Dividende je Aktie:  -
Dividendenrendite:  -
Dividendenschätzung:  -
Insiderhandel:  -
Suchwörter:  RTW BIOTECH
Letzte Datenerhebung:  02.04.26
>RTW BIOTECH Kennzahlen
Aktien/ Unternehmen:
Aktien: 328.17 Mio. St.
Frei handelbar: 73.71%
Leerverk. Aktien: -
Rückkaufquote: 1.07%
Mitarbeiter: -
Umsatz/Mitarb.: -
Analysten:
Analystenrating: No rating
Kursziel: -
Bewertung:
KGV: -
KGV lG: -
KUV: 10.47
KBV: 1.04
PEG-Ratio: -
EV/EBITDA: -
Rentabilität:
Bruttomarge: 86.74%
Gewinnmarge: -156.18%
Operative Marge: -144.82%
Managementeffizenz:
Gesamtkaprendite: -11.97%
Eigenkaprendite: -15.19%
>RTW BIOTECH Peer Group
Gesundheit, Zell- & Gentherapie/ Gentechnik/ Erbkrankheiten, Medizinprodukte & -technik/ Implantate/ Wundpflege
 
01.04.26 - 18:18
Apellis investors respond to $5.60 billion Biogen acquisition (Alliance)
 
Biotech Growth Trust PLC, International Biotechnology Trust PLC, ad RTW Biotech Opportunities Ltd have all noted the...
30.03.26 - 12:12
RTW Biotech net asset value grows healthily in 2025; outlook positive (Alliance)
 
RTW Biotech Opportunities Ltd on Monday said it is 'cautiously optimistic' looking ahead as it reported a sharply higher net...
21.01.26 - 13:12
IN BRIEF: RTW Biotech welcomes GSK deal to buy RAPT Therapeutics (Alliance)
 
RTW Biotech Opportunities Ltd - Guernsey-based investor in the life sciences sector - Notes GSK PLC's announcement on Tuesday...
16.01.26 - 11:18
RTW Biotech′s portfolio firm Penumbra acquired by Boston Scientific (Alliance)
 
RTW Biotech Opportunities Ltd on Thursday noted Boston Scientific Corp's $14.5 billion acquisition of Penumbra Inc, a...
18.12.25 - 13:12
RTW Biotech invests $5.9 million in Yarrow Bioscience funding round (Alliance)
 
RTW Biotech Opportunities Ltd on Thursday said it participated in the series A funding round of clinical stage biotechnology...
31.10.25 - 13:12
RTW Biotech announces royalty funding agreement with Savara (Alliance)
 
RTW Biotech Opportunities Ltd on Friday confirmed it has entered into a royalty funding agreement with clinical stage...
27.10.25 - 13:18
RTW Biotech hails Novartis acquisition of investee Avidity (Alliance)
 
RTW Biotech Opportunities Ltd on Monday noted that Swiss pharmaceutical major Novartis AG has definitively agreed to buy...
15.10.25 - 15:18
RTW Biotech invests $7.4 million in financing round for Kailera (Alliance)
 
RTW Biotech Opportunities Ltd said on Wednesday that it invested $7.4 million in Kailera Therapeutics Inc for the company's...
23.09.25 - 13:06
IN BRIEF: RTW Biotech lifts NAV on Biogen€s $85 million Alcyone deal (Alliance)
 
RTW Biotech Opportunities Ltd - Guernsey, Channel Islands-based investor in high-growth life science sectors - Notes Biogen...
11.09.25 - 12:12
RTW Biotech Opportunities NAV falls in €volatile€ period for biotech (Alliance)
 
RTW Biotech Opportunities Ltd on Thursday said the biotech industry is navigating a 'complex but increasingly constructive...
30.05.25 - 13:42
RTW Biotech notes mixed updates across portfolio companies (Alliance)
 
RTW Biotech Opportunities Ltd on Friday provided updates on three of its key listed holdings, highlighting both promising clinical trial results and a significant setback......
03.04.25 - 18:42
RTW Biotech Opportunities closes new investment with Airna (Alliance)
 
RTW Biotech Opportunities Ltd on Thursday announced a new investment into biotech company Airna, closing its oversubscribed $155 million series B financing round.The Guernsey, England-based......
31.03.25 - 14:36
RTW Biotech underperforms benchmark but optimistic for 2025 (Alliance)
 
RTW Biotech Opportunities Ltd on Monday said it underperformed its benchmarks during 2024, while total net asset value climbed following the takeover of Arix Bioscience......
>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!
Zitat des Tages: Don′t marry, be happy. - Hera Lind
>Aktien | >Anleihen | >ETFs | >Fonds | >Branchen | >Länder | >Themen | >Redaktionen
Partner:    >TradegateBSX Börse | >Dukascopy | >TradingView | >Boersentreff- Partner

Börsentreff auf Facebook | Börsentreff auf X | Börsentreff auf Instagram

Copyright @ Boersentreff.de - Die Märkte im Blick!